Search

everythinglearnresearchcommunity

for

Search:↓

DAVID syndrome is a condition with immune system and hormone deficiencies, needing early diagnosis to avoid serious complications.

Upadacitinib effectively treats psoriasis and lichen planus together.

AD-derived keratinocytes effectively mimic inflammation in atopic dermatitis.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Baricitinib treatment for severe alopecia areata shows significant improvement by 52 weeks, especially in very severe cases.

Cronkhite-Canada syndrome is a rare disorder needing early recognition and treatment with immunosuppressive therapies and nutritional support to manage symptoms and prevent complications.

Icariin can regulate macrophages and may help treat inflammation, cancer, bone disorders, and fibrotic diseases.

IL-1 blockade is effective for treating SURF, and personalized treatment is needed.

Always consider xanthomatous hypophysitis before deciding on pituitary surgery.

Ishige sinicola extract may help prevent muscle atrophy through its antioxidant and anti-inflammatory effects.

A new mutation in the ST14 gene was found in a patient with ARIH syndrome, showing milder symptoms and no tooth issues.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

A cross-bred lamb with severe skin and movement issues had ichthyosis fetalis but normal vitamin A levels.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Two siblings had a rare hair condition with banded hair, which doesn't need treatment.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Ocrelizumab may cause pancreatitis in some patients.

Epidermolysis bullosa in UK calves is not caused by mutations in keratin genes.

Consider TFI in facial hypopigmentation diagnoses and confirm with a biopsy.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

IL-23 inhibitors may help treat other skin conditions, but more research is needed.

Brodalumab is more effective than ustekinumab for treating psoriasis.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Baricitinib is a promising treatment for alopecia areata.

Diphencyprone therapy for hair loss can cause vitiligo.

Turning off a specific gene in stem cells speeds up skin healing by helping cells move better.